Status:
WITHDRAWN
Chlorhexidine Versus Betadine in Preventing Colonization of Femoral Nerve Catheters After Total Joint Arthroplasty (TJA)
Lead Sponsor:
Northwell Health
Conditions:
Infection
Eligibility:
All Genders
18-85 years
Phase:
NA
Brief Summary
Continuous femoral nerve block (CFNB) techniques continue to be increasingly used in the management of postoperative pain after total knee arthroplasty. Although the risk of full blown infection with ...
Detailed Description
After antisepsis four different cultures will be analyzed: 1. The femoral nerve catheter will be removed after 48 hours and a culture of the distal tip of the femoral nerve catheter will be performed...
Eligibility Criteria
Inclusion
- ASA 1-3,
- Undergoing primary total knee arthroplasty.
Exclusion
- Hypersensitivity/allergy to antiseptics,
- Recent opioid/alcohol abuse,
- Presence of contraindications to regional anesthesia,
- Coagulation disorder,
- Diabetic/femoral neuropathy,
- Prior surgery to inguinal area,
- Patient refusal.
Key Trial Info
Start Date :
July 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2015
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00896402
Start Date
July 1 2014
End Date
June 1 2015
Last Update
August 27 2015
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Syosset Hospital
Syosset, New York, United States, 11791
2
Franklin Hospital
Valley Stream, New York, United States, 11580